HY-10254-10mg
|
MedChemexpress LLC
|
Mirdametinib [CAS 391210-10-9]
|
|
Cancer-Kinase/protease
|
|
HY-10254-100mg
|
MedChemexpress LLC
|
Mirdametinib [CAS 391210-10-9]
|
|
Cancer-Kinase/protease
|
|
HY-10254-25mg
|
MedChemexpress LLC
|
Mirdametinib [CAS 391210-10-9]
|
|
Cancer-Kinase/protease
|
|
HY-10254-5mg
|
MedChemexpress LLC
|
Mirdametinib [CAS 391210-10-9]
|
|
Cancer-Kinase/protease
|
|
HY-10254-50mg
|
MedChemexpress LLC
|
Mirdametinib [CAS 391210-10-9]
|
|
Cancer-Kinase/protease
|
|
HY-10254-1mL
|
MedChemexpress LLC
|
Mirdametinib [CAS 391210-10-9] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
HY-N0316-1mg
|
MedChemexpress LLC
|
Mollugin [CAS 55481-88-4]
|
|
Cancer-programmed cell death
|
|
HY-N0316-10mg
|
MedChemexpress LLC
|
Mollugin [CAS 55481-88-4]
|
|
Cancer-programmed cell death
|
|
HY-N0316-20mg
|
MedChemexpress LLC
|
Mollugin [CAS 55481-88-4]
|
|
Cancer-programmed cell death
|
|
HY-N0316-5mg
|
MedChemexpress LLC
|
Mollugin [CAS 55481-88-4]
|
|
Cancer-programmed cell death
|
|
HY-N2036-1mg
|
MedChemexpress LLC
|
Mosloflavone [CAS 740-33-0]
|
|
COVID-19-anti-virus
|
|
HY-N2036-10mg
|
MedChemexpress LLC
|
Mosloflavone [CAS 740-33-0]
|
|
COVID-19-anti-virus
|
|
HY-N2036-5mg
|
MedChemexpress LLC
|
Mosloflavone [CAS 740-33-0]
|
|
COVID-19-anti-virus
|
|